Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers

類似資料

• A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
  著者:: Johansson, Susanne, 等
  出版事項: (2016)
• Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
  著者:: Peterschmitt, M. Judith, 等
  出版事項: (2020)
• Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
  著者:: Butler, Kathleen, 等
  出版事項: (2010)
• Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial
  著者:: S. B. Fitilev, 等
  出版事項: (2022-03-01)
• Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
  著者:: Al‐Karagholi, Mohammad Al‐Mahdi, 等
  出版事項: (2021)